期刊文献+

中药止咳橘红颗粒对CYP3A4和CYP1A2抑制作用的研究 被引量:18

The Inhibit Effect of Zhi-Ke-Ju-Hong on CYP3A4 and CYP1A2 Activity
下载PDF
导出
摘要 目的:在人体内研究止咳橘红对CYP3A4和CYP1A2的抑制作用,以预测 止咳橘红与常用临床药物的相互作用。方法:咪哒唑仑和咖啡因分别作为CYP3A4和 CYP1A2的探针药物,采取交叉设计,10名受试者在服用3d止咳 橘红的前后均服用7.5mg咪哒唑仑和100mg咖啡因,服药后采血测定两者及 代谢产物的代谢动力学参数。探针药物及代谢物的浓度用HPLC-MS法测定,Cmax、tmax从药时曲线中直接读出,AUC用梯形法计算,Ke用3P87程序进行拟合计算,分析服药前后CYP3A4和CYP1A2被抑制的情况。结果服用止咳橘红后,咪哒唑仑的代谢受到了轻微的抑制,它的血药浓度、达峰时间和药时曲线下面积都有了升高趋势,但无显著差异。而咖啡因的代谢未受到影响。结论止咳橘红对CYP3A4的活性有较弱的抑制作用,能够导致CYP3A4底物咪哒唑仑代谢的轻微抑制,而对CYP1A2的活性没有影响。止咳橘红长期使用或超过治疗剂量使用时是否会对CYP3A4产生显著性影响,尚需进一步的研究证明。 OBJECTIVE: To evaluate the inhibit effect of Zhi-Ke-Ju-Hong on CYP3A4 and CYP1A2 activity in ten volunteers and to forecast the drug-drug interaction with it. METHOD: In ten healthy male volunteers, use two-way cross design, taking 7.5mg midazolam and 100mg caffeine before and after three days Zhi-Ke-Ju-Hong administration, blood samples were collected. Plasma concentration of midazolam, caffeine and their metabolites were determined by high-performance liquid chromatography-mass spectrometry (HPLC-MS). CYP3A4 and CYP1A2 activity and Pharmacokinetic parameters of probe drugs were compared before and after Zhi-Ke-Ju-Hong administration. RESULTS:The metabolism of midazolam was inhibited slightly by Zhi-Ke-Ju-Hong. CYP3 A4, Cmax, tmax and AUC were all increased after three days Zhi-Ke-Ju-Hong administration, but not significant. t1/2 was significantly increased by Zhi-Ke-Ju-Hong administration (P< 0.05). No influences on caffeine metabolism were observed. CONCLUSION: Zhi-Ke-Ju-Hong can affect midazolam metabolism slightly. The possible reason is that some compositions of Zhi-Ke-Ju-Hong have inhibited effect on CYP3A4. Zhi-Ke-Ju-Hong have no inhibit effect on CYP1A2.
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2002年第3期215-218,共4页 The Chinese Journal of Clinical Pharmacology
关键词 止咳橘红 CYP3A4 CYP1A2 中药 Zhi-Ke-Ju-Hong CYP3A4 CYP1A2
  • 相关文献

参考文献24

  • 1[1]Shimada T, Yamazaki H, Mimura M, et al. Inteerindividual variations in human liver cytochrome P450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Janpanese and 30 Caucasians. J Pharmacol. Exp Ther, 1994, 270:414~423.
  • 2[2]Paine MF, Khalighi M, Fiser JM, et al. Characterization of interintestinal and interintestinal variations in human CYP3A dependent metabolism. J Pharmacol Exp. Ther, 1997;283:1552~1562.
  • 3[3]Wilkinson GR. Cytochrome P4503A(CYP3A) metabolism:prediction of in vivo activity in humans. J Pharmacokinet Biopharm, 1996, 24: 475~490.
  • 4[4]Guengerich FP. Cytochrome P4503A4: regulation and role in drug metabolism [review]. Annu Rev Pharmacol Toxicol,1999;39:1~17.
  • 5[5]Miniscalco A, Lundahl J, Regardh CG, et al. Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J Pharmacol Exp Ther, 1992,261; 1195~1199.
  • 6[6]Ameer B, Weintraub RA. Drug interactions with grapefruit juice.Clin Pharmacokinet, 1997;33: 103~121.
  • 7[7]HO PC, Saville DJ, Coville PF, et al. S. Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit juice and graprfruit juice products. Pharm Acta Helv,2000;74:379~385.
  • 8[8]Eagling VA, Profit L, Back DJ. Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components. Br J Clin Pharmacol, 1999;48: 543~552.
  • 9[9]Bailey DG, Kreeft JH, Munoz,C et al. Grapefruit juice-felodipine interaction: effect of naringin and 6',7'-dihydroxybergamottin in humans. Clin Pharmacol Ther, 1998;64:248~256.
  • 10[10]Edwards DJ, Bellevue III FH, Woster PM. Identification of 6',7' dihydroxybergamottin, a cytochrome P450 inhibitor in grapefruit juice. Drug Metab, Dispos, 1996; 1287~1290.

同被引文献294

引证文献18

二级引证文献95

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部